Section R386-900-8 - Official References(1) "Centers for Disease Control and Prevention (CDC), 2016, Program Guidance for Implementing Certain Components of Syringe Services Programs.(2) Federal Register, Health and Human Services Department, 2011, Determination That a Demonstration Needle Exchange Program Would be Effective in Reducing Drug Abuse and the Risk of Acquired Immune Deficiency Syndrome Infection Among Intravenous Drug Users.(3) Harm Reduction Coalition, 2006, Syringe Exchange Programs and Hepatitis C.(4) Harm Reduction Coalition, 2006, Syringe Exchange Programs: Reducing the Risks of NeedlestickNeedle stick Injuries.(5) Substance Abuse and Mental Health Services Administration (SAMHSA), Summary of Syringe Exchange Program Studies.(6) United States Department of Health and Human Services (HHS), 2016, Implementation Guidance to Support Certain Components of Syringe Services Programs.(7) World Health Organization (WHO), 2004, Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users.Utah Admin. Code R386-900-8
Adopted by Utah State Bulletin Number 2020-04, effective 1/31/2020